Interestingly, ACC activating mutations have been associated with liver carcinogenesis (Nakagawa et al., 2018) and ACC inhibition can protect against DEN-induced HCC in mice (Lally et al., 2019). The gene discussed is ACACA; the disease is hepatocellular carcinoma.